(Q35758344)

10 August 2017

title

International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe (English)

1 reference

10 August 2017

Sam Long

10

0 references

Andrea Fischer

Andrea Fischer

9

0 references

Kaspar Matiasek

Kaspar Matiasek

13

0 references

Luisa De Risio

Luisa De Risio

2

0 references

Clare Rusbridge

Clare Rusbridge

19

0 references

Mette Berendt

Mette Berendt

7

0 references

Heidrun Potschka

Heidrun Potschka

18

0 references

Simon R Platt

Simon Platt

16

0 references

Andrea Tipold

6

Andrea Tipold

1 reference

10 August 2017

Sofie F M Bhatti

1

1 reference

10 August 2017

Karen Muñana

3

1 reference

10 August 2017

Jacques Penderis

4

1 reference

10 August 2017

Veronika M Stein

5

1 reference

10 August 2017

Robyn G Farquhar

8

1 reference

10 August 2017

Wolfgang Löscher

11

1 reference

10 August 2017

Paul J J Mandigers

12

1 reference

10 August 2017

Akos Pakozdy

14

1 reference

10 August 2017

Edward E Patterson

15

1 reference

10 August 2017

Michael Podell

17

1 reference

10 August 2017

Holger A Volk

20

1 reference

10 August 2017

publication date

28 August 2015

1 reference

10 August 2017

published in

BMC Veterinary Research

1 reference

10 August 2017

volume

11

1 reference

10 August 2017

page(s)

176

1 reference

Creative Commons Attribution 4.0 International

10 August 2017

copyright license

start time

28 August 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s12917-015-0464-z

0 references

cites work

International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Assessment into the usage of levetiracetam in a canine epilepsy clinic

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Treatment in canine epilepsy--a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Antiepileptic drug therapy and monitoring

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A systematic review of the safety of potassium bromide in dogs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

High-performance liquid chromatographic analysis of lacosamide in canine serum using ultraviolet detection: application to pre-clinical pharmacokinetics in dogs.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Idiopathic epilepsy in dogs and cats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Selection of antiepileptic drugs in adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A systematic review of antiepileptic drug initiation and withdrawal

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Intrinsic severity as a determinant of antiepileptic drug refractoriness

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Transient leucopenia, thrombocytopenia and anaemia associated with severe acute phenobarbital intoxication in a dog.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The treatment of the first seizure: the benefits

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Topiramate: a review of its use in the treatment of epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Anticonvulsant therapy in dogs and cats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Felbamate: consensus of current clinical experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Euthyroid sick syndrome in dogs with idiopathic epilepsy before treatment with anticonvulsant drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The mechanisms of action of gabapentin and pregabalin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Zonisamide: chemistry, mechanism of action, and pharmacokinetics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetic interactions of topiramate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pregabalin pharmacology and its relevance to clinical practice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Clinical pharmacokinetics of levetiracetam

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The new antiepileptic drugs: scientific review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Influence of drugs on thyroid function in dogs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Do epileptic seizures damage the brain?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Initiation and discontinuation of antiepileptic drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Adverse reactions to new anticonvulsant drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Clinical pharmacology of topiramate: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Early identification of refractory epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Antiepileptic drug therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Use of bromide as an anticonvulsant for dogs with epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Surgery for epilepsy: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Superficial necrolytic dermatitis in 11 dogs with a history of phenobarbital administration (1995-2002).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Evaluation of risk factors for fatal acute pancreatitis in dogs.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Safety of topiramate: adverse events and relationships to dosing

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Felbamate modulates the strychnine-insensitive glycine receptor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Absorption kinetics and bioavailability of phenobarbital after oral administration to dogs.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Effectiveness of a therapeutic drug monitoring service as an aid to the control of canine seizures

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The pharmacokinetics of phenobarbitone in fasting and non-fasting dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Clinical evaluation of gamma-vinyl-gamma-aminobutyric acid for control of epilepsy in dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetics of felbamate in pediatric and adult beagle dogs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Update: seizure management in small animal practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Association between ABCB1 genotype and seizure outcome in Collies with epilepsy.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Zonisamide monotherapy for idiopathic epilepsy in dogs.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetics of oral rufinamide in dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Effect of prolonged status epilepticus as a result of intoxication on epileptogenesis in a UK canine population.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Possible drug-induced hepatopathy in a dog receiving zonisamide monotherapy for treatment of cryptogenic epilepsy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Cytochrome P450 induction by phenobarbital exacerbates warm hepatic ischemia-reperfusion injury in rat livers.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetics of single-dose oral pregabalin administration in normal dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Premature death, risk factors, and life patterns in dogs with epilepsy.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Dyskinesia associated with oral phenobarbital administration in a dog.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Cognitive function in preschool children after epilepsy surgery: rationale for early intervention.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Zonisamide therapy for refractory idiopathic epilepsy in dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A cross-sectional study of epilepsy in Danish Labrador Retrievers: prevalence and selected risk factors.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosage regimen in dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Treatment of partial seizures and seizure-like activity with felbamate in six dogs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Chronic phenobarbital therapy reduces plasma benzodiazepine concentrations after intravenous and rectal administration of diazepam in the dog.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Evaluation of case reports of aplastic anemia among patients treated with felbamate

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 labrador retrievers: a long-term study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Effects of a 44-day administration of phenobarbital on disposition of clorazepate in dogs.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Sequential neuropathology of dogs treated with vigabatrin, a GABA-transaminase inhibitor.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

Kinetics of phenobarbital in normal subjects and epileptic patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552371

A Cross-Sectional Study of Epilepsy in Danish Labrador Retrievers: Prevalence and Selected Risk Factors

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS12917-015-0464-Z

A Longitudinal Study of Survival in Belgian Shepherds with Genetic Epilepsy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS12917-015-0464-Z

The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics and bioavailability of topiramate in the beagle dog

1 reference

12 December 2020

Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy

1 reference

12 December 2020

Infantile bromoderma due to antiepileptic therapy

1 reference

12 December 2020

Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs

1 reference

12 December 2020

Apparent acute idiosyncratic hepatic necrosis associated with zonisamide administration in a dog

1 reference

12 December 2020

Management of childhood epilepsy

1 reference

12 December 2020

Temporal lobe epilepsy with hippocampal sclerosis: predictors for long-term surgical outcome

1 reference

12 December 2020

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

12 December 2020

MRI monitoring of vigabatrin-induced intramyelinic edema in dogs

1 reference

12 December 2020

Effects of long-term phenobarbital treatment on the liver in dogs

1 reference

12 December 2020

Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996)

1 reference

12 December 2020

Epilepsy in Border Collies: clinical manifestation, outcome, and mode of inheritance

1 reference

12 December 2020

Bromide toxicosis secondary to renal insufficiency in an epileptic dog

1 reference

12 December 2020

Renal tubular acidosis associated with zonisamide therapy in a dog

1 reference

12 December 2020

Pharmacokinetic properties of bromide in dogs after the intravenous and oral administration of single doses

1 reference

12 December 2020

Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989)

1 reference

12 December 2020

Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles

1 reference

12 December 2020

Pharmacokinetics of primidone and its active metabolites in the dog

1 reference

12 December 2020

Pharmacokinetics of phenobarbital in dogs given multiple doses

1 reference

12 December 2020

Gabapentin interaction with felbamate

1 reference

12 December 2020

A multi-mode chromatographic method for the comparison of the N-glycosylation of a recombinant HIV envelope glycoprotein (gp160s-MN/LAI) purified by two different processes

1 reference

12 December 2020

Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs

1 reference

12 December 2020

Use of anticonvulsants in small animals

1 reference

12 December 2020

Topiramate as an add-on antiepileptic drug in treating refractory canine idiopathic epilepsy

1 reference

12 December 2020

Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration

1 reference

12 December 2020

Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs

1 reference

12 December 2020

Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy

1 reference

12 December 2020

Effect of dietary chloride content on the elimination of bromide by dogs

1 reference

12 December 2020

Polymorphisms in the ABCB1 gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies

1 reference

12 December 2020

Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys

1 reference

12 December 2020

Bromide therapy in refractory canine idiopathic epilepsy

1 reference

12 December 2020

Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs

1 reference

12 December 2020

Pharmacokinetics of phenobarbital in dogs after multiple oral administration

1 reference

12 December 2020

Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy

1 reference

12 December 2020

Variations in serum concentration of phenobarbitone in dogs receiving regular twice daily doses in relation to the times of administration

1 reference

12 December 2020

10.1186/S12917-015-0464-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference